Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Journal of Clinical Pharmacology
|
July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials
M A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Annals of the Rheumatic Diseases
|
November 29, 2013
The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
M A Karsdal, A C Bay-Jensen, R J Lories, et al.
Osteoarthritis and Cartilage
|
November 30, 2011
Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus
B C Sondergaard, P Catala-Lehnen, A K Huebner, et al.
The Journal of Cell Biology
|
November 15, 2000
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
M T Engsig, Q J Chen, T H Vu, et al.
Alzheimer'S Research & Therapy
|
August 24, 2021
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD
E G B Vijverberg, T M Axelsen, A R Bihlet, et al.
British Journal of Pharmacology
|
April 18, 2012
Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats
M Feigh, K V Andreassen, A V Neutzsky-Wulff, et al.
Clinical Biochemistry
|
August 17, 2010
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes
D J Leeming, D V Larsen, C Zhang, et al.
JAMA Network Open
|
November 9, 2021
Nonpharmacological Treatment of Persistent Postconcussion Symptoms in Adults: A Systematic Review and Meta-analysis and Guideline Recommendation
Hana Malá Rytter, Heidi J Graff, Henriette K Henriksen, et al.
Clinical and Experimental Rheumatology
|
February 21, 2012
Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis
H Skjøt-Arkil, G Schett, C Zhang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
April 29, 2009
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development
M A Karsdal, K Henriksen, D J Leeming, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Journal of Clinical Pharmacology
|
July 28, 2010
Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials
M A Karsdal, K Henriksen, A C Bay-Jensen, et al.
Annals of the Rheumatic Diseases
|
November 29, 2013
The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
M A Karsdal, A C Bay-Jensen, R J Lories, et al.
Osteoarthritis and Cartilage
|
November 30, 2011
Mice over-expressing salmon calcitonin have strongly attenuated osteoarthritic histopathological changes after destabilization of the medial meniscus
B C Sondergaard, P Catala-Lehnen, A K Huebner, et al.
The Journal of Cell Biology
|
November 15, 2000
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones
M T Engsig, Q J Chen, T H Vu, et al.
Alzheimer'S Research & Therapy
|
August 24, 2021
Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD
E G B Vijverberg, T M Axelsen, A R Bihlet, et al.
British Journal of Pharmacology
|
April 18, 2012
Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats
M Feigh, K V Andreassen, A V Neutzsky-Wulff, et al.
Clinical Biochemistry
|
August 17, 2010
Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes
D J Leeming, D V Larsen, C Zhang, et al.
JAMA Network Open
|
November 9, 2021
Nonpharmacological Treatment of Persistent Postconcussion Symptoms in Adults: A Systematic Review and Meta-analysis and Guideline Recommendation
Hana Malá Rytter, Heidi J Graff, Henriette K Henriksen, et al.
Clinical and Experimental Rheumatology
|
February 21, 2012
Investigation of two novel biochemical markers of inflammation, matrix metalloproteinase and cathepsin generated fragments of C-reactive protein, in patients with ankylosing spondylitis
H Skjøt-Arkil, G Schett, C Zhang, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
April 29, 2009
Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development
M A Karsdal, K Henriksen, D J Leeming, et al.
Page
of 10